Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 4 studies | 28% ± 19% | |
microglial cell | 4 studies | 23% ± 4% |
Insufficient scRNA-seq data for expression of ADAMTSL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 1182.36 | 2544 / 2642 | 99% | 19.22 | 699 / 705 |
thymus | 100% | 2524.07 | 653 / 653 | 92% | 16.19 | 556 / 605 |
lung | 100% | 4502.28 | 578 / 578 | 84% | 10.50 | 970 / 1155 |
pancreas | 87% | 766.77 | 284 / 328 | 97% | 34.08 | 172 / 178 |
prostate | 98% | 1724.19 | 239 / 245 | 83% | 6.94 | 419 / 502 |
adrenal gland | 100% | 5202.66 | 258 / 258 | 81% | 25.63 | 186 / 230 |
kidney | 99% | 4447.99 | 88 / 89 | 78% | 10.76 | 699 / 901 |
liver | 100% | 3536.70 | 226 / 226 | 72% | 15.55 | 292 / 406 |
esophagus | 63% | 474.35 | 905 / 1445 | 77% | 5.96 | 141 / 183 |
bladder | 67% | 991.00 | 14 / 21 | 70% | 6.17 | 355 / 504 |
intestine | 63% | 436.32 | 605 / 966 | 74% | 7.84 | 391 / 527 |
stomach | 40% | 229.16 | 142 / 359 | 78% | 8.98 | 224 / 286 |
breast | 33% | 188.40 | 150 / 459 | 81% | 7.66 | 903 / 1118 |
ovary | 63% | 833.27 | 114 / 180 | 50% | 3.83 | 214 / 430 |
uterus | 55% | 424.95 | 93 / 170 | 47% | 5.25 | 217 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.42 | 1 / 1 |
heart | 91% | 5518.59 | 786 / 861 | 0% | 0 | 0 / 0 |
spleen | 88% | 1211.75 | 213 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 3.74 | 28 / 45 |
adipose | 61% | 505.79 | 735 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 4.82 | 16 / 29 |
skin | 5% | 20.81 | 84 / 1809 | 38% | 2.82 | 179 / 472 |
blood vessel | 41% | 484.04 | 549 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 33% | 1.60 | 26 / 80 |
muscle | 31% | 270.05 | 245 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 3.71 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0060481 | Biological process | lobar bronchus epithelium development |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0005576 | Cellular component | extracellular region |
GO_0031012 | Cellular component | extracellular matrix |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0050436 | Molecular function | microfibril binding |
Gene name | ADAMTSL2 |
Protein name | ADAMTS-like protein 2 (ADAMTSL-2) ADAMTS like 2 |
Synonyms | KIAA0605 |
Description | |
Accessions | Q86TH1 B1B0D4 ENST00000393061.7 ENST00000651351.2 ENST00000354484.8 ENST00000393060.1 |